Comparison timestamp: 2025-05-07 02:24:52 UTC
RestoredCDC URL: http://restoredcdc.org/www.cdc.gov/acip-recs/hcp/vaccine-specific/covid-19.html
Live cdc.gov URL ↗: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/covid-19.html
RestoredCDC URL: http://restoredcdc.org/www.cdc.gov/acip-recs/hcp/vaccine-specific/covid-19.html
Live cdc.gov URL ↗: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/covid-19.html
Removed: Line removed from cdc.gov. Specific word removals are highlighted.
Added: Line added to cdc.gov. Specific word additions are highlighted.
Injected:
Line or disclaimer added by RestoredCDC.org.
Unchanged: Line unchanged.
Original site: www.cdc.gov/acip-recs/hcp/vaccine-specific/covid-19.html | RestoredCDC.org is an independent project, not affiliated with CDC or any federal entity. Visit CDC.gov for free official information. Due to archival on January 6, 2025, recent outbreak data is unavailable. Videos are not restored. Access data.restoredcdc.org for restored data. Use of this site implies acceptance of this disclaimer.[More]About Us Report Bug Compare ContentSkip directly to site content Skip directly to search Skip directly to On This PageAn official website of the United States governmentHere's how you knowOfficial websites use .govA .gov website belongs to an official government organization in the United States.Secure .gov websites use HTTPSA lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.ACIP Vaccine Recommendations and GuidelinesExplore TopicsSearchSearchClear InputHealth Care Providers* Vaccine-Specific Recommendations* Archived ACIP Recommendations* Recommendations by Date* View allRelated Topics:Advisory Committee on Immunization Practices (ACIP) | ACIP GRADE Handbook | Vaccines & ImmunizationsView Allsearch close searchsearchACIP Recommendations Menu CloseACIP Recommendations MenusearchHealth Care Providers* Vaccine-Specific Recommendations* Archived ACIP Recommendations* Recommendations by Date* View AllRelated Topics* Advisory Committee on Immunization Practices (ACIP)* ACIP GRADE Handbook* Vaccines & ImmunizationsView All ACIP RecommendationsVaccine-Specific Recommendations Archived ACIP Recommendations Recommendations by Date View AllJuly 25, 2024December 18, 2024ACIP Recommendations: COVID-19 VaccineAdvisory Committee on Immunization Practices (ACIP)Key points* The Advisory Committee on Immunization Practices (ACIP) develops recommendations on how to use vaccines to control disease in the United States.* These recommendations become official CDC policy once adopted by CDC's Director.* Learn about current and historical ACIP recommendations for COVID-19 vaccine.Published in Morbidity and Mortality Weekly Report (MMWR)The Advisory Committee on Immunization Practices (ACIP) provides advice and guidance to the Director of the CDC regarding use of vaccines and related agents for control of vaccine-preventable diseases in the civilian population of the United States. Recommendations made by the ACIP are reviewed by the CDC Director and, if adopted, are published as official CDC/HHS recommendations in the Morbidity and Mortality Weekly Report (MMWR).Keep Reading: See Clinical Considerations for Use of COVID-19 VaccinesCURRENT COVID-19 Vaccine RecommendationsMMWR, December 12, 2024. Vol 73 (49); 1118-1123Use of Additional Doses of 2024–2025 COVID-19 Vaccine for Adults Aged ≥65 Years and Persons Aged ≥6 Months with Moderate or Severe Immunocompromise: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024Print versionMMWR, September 10, 2024. Vol 73 (37);819-824Use of COVID-19 Vaccines for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024–2025.Print versionARCHIVED COVID-19 Immunization PublicationsFor your convenience, these archived publications can be used for historical and research purposes.MMWR, April 25, 2024, Vol 73(16);377-381Use of an Additional Updated 2023–2024 COVID-19 Vaccine Dose for Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024Print versionMMWR, October 20, 2023, Vol 72(42);1140–1146Use of Updated COVID-19 Vaccines 2023–2024 Formula for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2023Print versionMMWR, June 16, 2023, Vol 72(24);657–662Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged ≥6 Months — United States, April 2023Print versionMMWR, November 11, 2022, Vol 71(45); 1436-1441Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines — United States, October 2022 | MMWR (cdc.gov)Print versionMMWR, August 4, 2022, Vol 71(31); 988-992Interim Recommendation of the Advisory Committee on Immunization Practices for use of the Novavax COVID-19 vaccine in persons aged 18 years and older— United States, July 2022Print versionMMWR, June 28, 2022, Vol 71(26);859–868Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months–5 Years — United States, June 2022Print versionMMWR, March 18, 2022, Vol 71(11);416–421Use of Moderna COVID-19 Vaccine in Persons Aged ≥18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines — United States, February 2022Print versionMMWR, January 21, 2022, Vol 71(3);90–95Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices – United States, December 2021Print versionMMWR, November 5, 2021, Vol 70(45);1579–1583Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, November 2021Print versionMMWR, November 5, 2021, Vol 70(44);1545–1552Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines — United States, 2021Print versionMMWR, September 24, 2021, Vol 70(38);1344–1348Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2021Print versionMMWR, August 13, 2021, Vol 70(32);1094-1099Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021Print versionMMWR, July 9, 2021, Vol 70(27);977–982Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021Print versionMMWR, May 14, 2021, Vol 70(20);749–752The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12–15 Years — United States, May 2021Print versionMMWR, April 30, 2021, Vol 70(17);651-656Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients — United States, April 2021Print versionMMWR, March 2, 2021, Vol 70(9);329–332The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Janssen COVID-19 Vaccine — United States, February 2021Print versionMMWR, December 22, 2020, Vol 69(5152);1657-1660The Advisory Committee on Immunization Practices' Updated Interim Recommendation for Allocation of COVID-19 Vaccine — United States, December 2020Print versionMMWR, December 20, 2020, Vol 69(5152);1653-1656The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Moderna COVID-19 Vaccine — United States, December 2020Print versionMMWR, December 13, 2020, Vol 69(50);1922-1924The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020Print versionMMWR, December 3, 2020, Vol 69(49);1857-1859The Advisory Committee on Immunization Practices' Interim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine — United States, 2020Print versionOn This Page* Published in Morbidity and Mortality Weekly Report (MMWR)* CURRENT COVID-19 Vaccine Recommendations* ARCHIVED COVID-19 Immunization PublicationsRelated PagesVaccine-Specific RecommendationsRelated Pages** Vaccine-Specific Recommendations* Anthrax* Cholera** Dengue* DTaPHiba>* DTaP/IPV/Hib/HepBView AllView All ACIP RecommendationsDengueBack to TopDecember 18, 2024July 25, 2024Sources Print ShareFacebook LinkedIn Twitter SyndicateContent Source:National Center for Immunization and Respiratory Diseases (NCIRD)Related PagesVaccine-Specific RecommendationsRelated Pages** Vaccine-Specific Recommendations* Anthrax* Cholera** Dengue* DTaPHiba>* DTaP/IPV/Hib/HepBView AllView All ACIP RecommendationsBack to TopACIP RecommendationsFind a complete list of ACIP recommendations published in the MMWR.View All* Vaccine-Specific Recommendations* Archived ACIP Recommendations* Recommendations by DateSign up for Email UpdatesContact UsContact Us* Call 800-232-4636* Contact CDCAbout CDCAbout CDC* Pressroom* Organization* Budget & Funding* Careers & JobsPolicies* Accessibility* External Links* Privacy* Web Policies* FOIA* OIG* No Fear Act* Nondiscrimination* Vulnerability Disclosure PolicyLanguagesLanguages* EspañolLanguage Assistance* Español* 繁體中文* Tiếng Việt* 한국어* Tagalog* Русский* العربية* Kreyòl Ayisyen* Français* Polski* Português* Italiano* Deutsch* 日本語* فارسی* EnglishArchive* CDC Archive* Public Health PublicationsContact UsContact Us* Call 800-232-4636* Contact CDCAbout CDC* Pressroom* Organization* Budget & Funding* Careers & Jobs* About CDCPolicies* Accessibility* External Links* Privacy* Web Policies* FOIA* OIG* No Fear Act* Nondiscrimination* Vulnerability Disclosure PolicyLanguagesLanguages* EspañolLanguage Assistance* Español* 繁體中文* Tiếng Việt* 한국어* Tagalog* Русский* العربية* Kreyòl Ayisyen* Français* Polski* Português* Italiano* Deutsch* 日本語* فارسی* EnglishArchive* CDC Archive* Public Health PublicationsHHS.gov USA.gov
Note: Comparison ignores leading/trailing whitespace
and certain script/tracking codes. Word-level
highlighting (optional above) only applies to changed
lines.